USPTO serial 79097099
SCINTOMICS
Reviewed by CopyMark Law Group
Reg. 4398176Status 404
- Filing date
- Status date
- Registration date
- Sep 10, 2013
- Examiner
- BIBB, SCOTT
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SCINTOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marta L. Paul
Marta L. Paul Woodard Emhardt Henry Reeves & Wagner LLP111 Monument Circle, Suite 3700Indianapolis, IN 46204UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signaling, checking, supervising, life-saving and teaching apparatus and instruments, namely, automated apparatus and analytical instruments in the nature of computers, microscopes, scanners; computer software for production, handling, dispensing and analysis of radiopharmaceuticals, radioactive contrast agents and precursors thereof as molecular imaging agents and endoradiopharmaceuticals for preclinical, clinical, medical, veterinary, and in vivo and in vitro use and research; video screens, spectrometers, dispensers of preset portions of fluids for dosing purposes and not for medical use; radioisotopic labeling machines for use in radiopharmaceutical technology, namely, machines for chemical introduction of radiolabelled isotopes into molecules resulting in a radiopharmaceutical for the purification and the final sterile filtration of the aforementioned radiopharmaceutical; electrical control devices for all the afore-said goods; ] modules for the production of Ga-labelled peptides, synthesizers, namely, synthesizers for the automated Ga-labelling of peptides, for radiolabelling, isotope purification, routine tracer production and other radiopharmaceutical processes, modules for the production of Ga-labelled peptides; [ synthesizers, namely, synthezizers for the automated radiolabelling of pharmaceuticals, for isotope purification, routine tracer production and other radiopharmaceutical processes; tracer production platforms, namely, laboratory equipment for production, dispensing, handling and analysis of radioactive chemicals, compounds and pharmaceuticals, namely, synthesizers, cassettes, dispensers, quality control apparatus therefor in the form of a thin layer radio chromatography and/or a high performance liquid radiochromatography as quality control apparatus; sensing and signaling devices for controlling the quality of synthesized radiopharmaceuticals; compact radiosynthesis platforms, namely, laboratory equipment for production, dispensing, handling and analysis of radioactive chemicals, compounds and pharmaceuticals, namely, synthesizers, cassettes, dispensers, quality control apparatus therefor in the form of a thin layer radio chromatography and/or a high performance liquid radiochromatography as quality control apparatus; sensing and signaling devices for controlling the quality of synthesized radiopharmaceuticals; ] automated modules for the dispensing of radiopharmaceuticals for laboratory use; [ computer software for facilitating gmp report generators and the editing of labels; control interfaces, namely, electronic display interfaces, motor syringes, namely, disposable reusable dispenser syringes for laboratory use; ] vario Tec-based modules and fully automated four capillary reactor microfluidic modules in the nature of computer hardware; fully automated dispensing units for single dose dispensing into vials or syringes for laboratory use; [ medical laboratory machines, namely, radiopharmaceutical synthesizing machines comprised of a series of valves, tubing, and reaction vials used to make radioisotope drugs; medical apparatus for preparing hazardous drugs, namely, radioactive injectables consisting of a medical robot designed to assist personnel in preparing drugs in radiopharmacies, radioactive laboratories, or in hospital settings, all the aforementioned goods used for the production, handling, dispensing and analysis of radiopharmaceuticals, radioactive contrast agents and precursors thereof as molecular imaging agents and endoradiotherapeuticals for preclinical, clinical, medical, veterinary and in vivo and in vitro use and research; apparatus and instruments for the conducting, switching, transforming, accumulating, regulating and controlling of data in the nature of flow meters, [ conductivity meters, ] calibration devices for calibrating the dosing of radioactive radiation not for medical use, calibration devices for calibrating optical emission spectrometers, atomic absorption spectrometers and X-ray apparatus, other than for medical use; all of the aforementioned goods used for the production, handling, dispensing and analysis of radiopharmaceuticals, radioactive contrast agents and precursors thereof as molecular imaging agents and endoradiotherapeuticals for preclinical, clinical, medical, veterinary and in vivo and in vitro use and research; apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, data processing equipment and computers; computer software for use in the control and monitoring of automated process for the production, handling, dispensing and analysis of radiopharmaceuticals, radioactive contrast agents and precursors thereof as molecular imaging agents and endoradiotherapeuticals for preclinical, clinical, medical, veterinary and in vivo and in vitro use and research; computer hardware and electronic computer hardware components ] | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 13, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 13, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 6, 2021 | IRIV | IRREGULARITY ON INVALIDATION RECEIVED FROM IB | — |
| Mar 19, 2021 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 19, 2021 | INPC | INVALIDATION PROCESSED | — |
| Mar 14, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 14, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jul 14, 2020 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 30, 2020 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Apr 28, 2020 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Mar 11, 2020 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Sep 11, 2019 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Sep 11, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 5, 2019 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Sep 10, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 31, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 30, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 11, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 11, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 10, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 10, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 17, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 25, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 25, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 5, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 5, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 5, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 20, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 19, 2013 | EXPT | EXPARTE APPEAL TERMINATED | — |
| May 17, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 21, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 21, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 18, 2013 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 22, 2013 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jan 22, 2013 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jan 22, 2013 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Nov 24, 2012 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 20, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 20, 2012 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 20, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 20, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 7, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 7, 2012 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 8, 2012 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 8, 2012 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Aug 8, 2012 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jul 19, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2012 | ALIE | ASSIGNED TO LIE | — |
| Jul 9, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 9, 2012 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 9, 2012 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 9, 2012 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jan 9, 2012 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 9, 2012 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 9, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 12, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 12, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 4, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 13, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 13, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 11, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 10, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 3, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 2, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |